Oxytocin antagonists: the next frontier in PE treatment
Crossref DOI link: https://doi.org/10.1038/s41585-019-0238-7
Published Online: 2019-09-24
Published Print: 2019-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Gul, Murat http://orcid.org/0000-0002-6657-6227
Serefoglu, Ege Can
Text and Data Mining valid from 2019-09-24
Version of Record valid from 2019-09-24
Article History
First Online: 24 September 2019
Competing interests
: The authors declare no competing interests.